Actinium Pharmaceuticals, Inc.: Form 8-K/A, filed Mar 26, 2026
Filed with the SEC on Mar 26, 2026 and accepted by EDGAR at Mar 26, 2026, 21:00 ET.
Items reported
- Item 5.07 Shareholder vote results
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0001213900-26-034807. Last ingested by Listed: Oct 24, 2026, 15:12 ET. Listed shows no prices and gives no investment advice.